Corneal Crosslinking in Keratoconus and Corneal Ectasia
Status:
Withdrawn
Trial end date:
2010-10-01
Target enrollment:
Participant gender:
Summary
Prospective, randomized, single site to determine the safety and effectiveness of performing
corneal collagen cross-linking (CXL) using riboflavin and UVA light in eyes progressive
keratoconus or corneal ectasia.